Suramin inhibits chikungunya virus entry and transmission

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Ho, Yi Jung ^a   Wang, Yu Ming ^a   Lu, Jeng Wei ^b   Wu, Tzong Yuan ^c   Lin, Liang In ^b,d   Kuo, Szu Cheng ^a   Lin, Chang Chi ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

SURAMIN; VIRUS GLYCOPROTEIN; VIRUS PROTEIN; VIRUS RNA; ANTIVIRUS AGENT; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CHIKUNGUNYA VIRUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG STRUCTURE; EMBRYO; MOLECULAR DOCKING; NONHUMAN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS RELEASE; VIRUS STRAIN; VIRUS TRANSMISSION; WESTERN BLOTTING; ANIMAL; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; CHIKUNGUNYA; CONFORMATION; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; VIRAL PLAQUE ASSAY; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; SURAMIN; VIRAL ENVELOPE PROTEINS; VIRAL PLAQUE ASSAY; VIRUS INTERNALIZATION; VIRUS RELEASE;

EID: 84941670896     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133511     Document Type: Article

References (53)

1. Higgs S (2006) The 2005-2006 Chikungunya epidemic in the Indian Ocean. Vector Borne Zoonotic Dis 6: 115-116. PMID: 16796508.
2. Renault P, Solet JL, Sissoko D, Balleydier E, Larrieu S, Filleul L, et al. (2007) A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006. Am J Trop Med Hyg 77: 727-731. PMID: 17978079.
3. Khan K, Bogoch I, Brownstein JS, Miniota J, Nicolucci A, Hu W, et al. (2014) Assessing the origin of and potential for international spread of chikungunya virus from the Caribbean. PLoS Curr 6.
4. Fischer M, Staples JE, Arboviral Diseases Branch NCfE, Zoonotic Infectious Diseases CDC, et al. (2014) Notes from the field: chikungunya virus spreads in the Americas-Caribbean and South America, 2013-2014. MMWR Morb Mortal Wkly Rep 63: 500-501. PMID: 24898168.
5. Morrison TE (2014) Reemergence of chikungunya virus. J Virol 88: 11644-11647. doi:10.1128/JVI.01432-14 PMID: 25078691.
6. Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT. (2012) Chikungunya: A re-emerging virus. Lancet 379: 662-671. doi:10.1016/S0140-6736(11)60281-X PMID: 22100854.
7. Schwartz O, Albert ML (2010) Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol 8: 491-500. doi:10.1038/nrmicro2368 PMID: 20551973.
8. Couderc T, Chretien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, et al. (2008) A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog 4: e29. doi:10.1371/journal.ppat.0040029 PMID: 18282093.
9. Noret M, Herrero L, Rulli N, Rolph M, Smith PN, Li RW, et al. (2012) Interleukin 6, RANKL, and osteoprotegerin expression by chikungunya virus-infected human osteoblasts. J Infect Dis 206: 455-457: 457-459. doi:10.1093/infdis/jis368 PMID: 22634878.
10. Ozden S, Huerre M, Riviere JP, Coffey LL, Afonso PV, Mouly V, et al. (2007) Human muscle satellite cells as targets of Chikungunya virus infection. PLoS One 2: e527. PMID: 17565380.
11. Her Z, Malleret B, Chan M, Ong EK, Wong SC, Kwek DJ, et al. (2010) Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response. J Immunol 184: 5903-5913. doi:10.4049/jimmunol.0904181 PMID: 20404274.
12. Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, et al. (2010) Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 120: 894-906. doi:10.1172/JCI40104 PMID: 20179353.
13. Rochlin I, Ninivaggi DV, Hutchinson ML, Farajollahi A (2013) Climate change and range expansion of the Asian tiger mosquito (Aedes albopictus) in Northeastern USA: implications for public health practitioners. PLoS One 8: e60874. doi:10.1371/journal.pone.0060874 PMID: 23565282.
14. Voss JE, Vaney MC, Duquerroy S, Vonrhein C, Girard-Blanc C, Crublet E, et al. (2010) Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature 468: 709-712. doi:10.1038/nature09555 PMID: 21124458.
15. Hahon N, Zimmerman WD (1970) Chikungunya virus infection of cell monolayers by cell-to-cell and extracellular transmission. Appl Microbiol 19: 389-391. PMID: 4908535.
16. Soonsawad P, Xing L, Milla E, Espinoza JM, Kawano M, Marko M, et al. (2010) Structural evidence of glycoprotein assembly in cellular membrane compartments prior to Alphavirus budding. J Virol 84: 11145-11151. doi:10.1128/JVI.00036-10 PMID: 20739526.
17. Garoff H, Sjoberg M, Cheng RH. (2004) Budding of alphaviruses. Virus Res 106: 103-116. PMID: 15567491.
18. Lee CY, Kam YW, Fric J, Malleret B, Koh EG, Prakash C, et al. (2011) Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants. PLoS Pathog 7: e1002390. doi:10.1371/journal.ppat.1002390 PMID: 22144891.
19. Mitsuya H, Popovic M, Yarchoan R, Matsushita S, Gallo RC, Broder S. (1984) Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III. Science 226: 172-174. PMID: 6091268.
20. Yahi N, Sabatier JM, Nickel P, Mabrouk K, Gonzalez-Scarano F, Fantini J. (1994) Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV- 1 gp120 on human colon epithelial cells. J Biol Chem 269: 24349-24353. PMID: 7929093.
21. Aguilar JS, Rice M, Wagner EK. (1999) The polysulfonated compound suramin blocks adsorption and lateral difusion of herpes simplex virus type-1 in vero cells. Virology 258: 141-151. PMID: 10329576.
22. Kessler HA, Pottage JC Jr., Trenholme GM, Benson CA, Levin S. (1986) Effects of suramin on in vitro HBsAg production by PLC/PRF/5 cells and hepatitis B virus DNA polymerase activity. AIDS Res 2: 63-72. PMID: 2424468.
23. Garson JA, Lubach D, Passas J, Whitby K, Grant PR. (1999) Suramin blocks hepatitis C binding to human hepatoma cells in vitro. J Med Virol 57: 238-242. PMID: 10022794.
24. Basavannacharya C, Vasudevan SG (2014) Suramin inhibits helicase activity of NS3 protein of dengue virus in a fluorescence-based high throughput assay format. Biochem Biophys Res Commun. 453: 539-44. doi:10.1016/j.bbrc.2014.09.113 PMID: 25281902.
25. Xu K, Ren H, Zhu J, Yang Y, Liao F (2003) Suramin inhibits the in vitro expression of encephalitis B virus proteins NS3 and E. J Huazhong Univ Sci Technolog Med Sci 23: 375-379. PMID: 15015640.
26. Jiao L, Ouyang S, Liang M, Niu F, Shaw N, Wu W, et al. (2013) Structure of severe fever with thrombocytopenia syndrome virus nucleocapsid protein in complex with suramin reveals therapeutic potential. J Virol 87: 6829-6839. doi:10.1128/JVI.00672-13 PMID: 23576501.
27. Croci R, Pezzullo M, Tarantino D, Milani M, Tsay SC, Sureshbabu R, et al. (2014) Structural bases of norovirus RNA dependent RNA polymerase inhibition by novel suramin-related compounds. PLoS One 9: e91765. doi:10.1371/journal.pone.0091765 PMID: 24622391.
28. Wang Y, Qing J, Sun Y, Rao Z. (2014) Suramin inhibits EV71 infection. Antiviral Res 103: 1-6. doi:10.1016/j.antiviral.2013.12.008 PMID: 24374150.
29. Ellenbecker M, Lanchy JM, Lodmell JS. (2014) Inhibition of Rift Valley fever virus replication and perturbation of nucleocapsid-RNA interactions by suramin. Antimicrob Agents Chemother.
30. Huang JH, Yang CF, Su CL, Chang SF, Cheng CH, Yu SK, et al. (2009) Imported chikungunya virus strains, Taiwan, 2006-2009. Emerg Infect Dis 15: 1854-1856. doi:10.3201/eid1511.090398 PMID: 19891886.
31. Kuo SC, Chen YJ, Wang YM, Kuo MD, Jinn TR, Chen WS, et al. (2011) Cell-based analysis of Chikungunya virus membrane fusion using baculovirus-expression vectors. J Virol Methods 175: 206-215. doi:10.1016/j.jviromet.2011.05.015 PMID: 21619896.
32. Shih SR, Horng JT, Poon LL, Chen TC, Yeh JY, Hsieh HP, et al. (2010) BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses. J Antimicrob Chemother 65: 63-71. doi:10.1093/jac/dkp393 PMID: 19892833.
33. Cruz DJ, Bonotto RM, Gomes RG, da Silva CT, Taniguchi JB, No JH, et al. (2013) Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor library. PLoS Negl Trop Dis 7: e2471. doi:10.1371/journal.pntd.0002471 PMID: 24205414.
34. Moghaddam E, Teoh BT, Sam SS, Lani R, Hassandarvish P, Chik Z, et al. (2014) Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci Rep 4: 5452. doi:10.1038/srep05452 PMID: 24965553.
35. Kuo SC, Chen YJ, Wang YM, Tsui PY, Kuo MD, Wu TY, et al. (2012) Cell-based analysis of Chikungunya virus E1 protein in membrane fusion. J Biomed Sci 19: 44. doi:10.1186/1423-0127-19-44 PMID: 22520648.
36. Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ. (2005) Patch Dock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res 33: W363-W367. PMID: 15980490.
37. Lammer E, Carr GJ, Wendler K, Rawlings JM, Belanger SE. (2009) Is the fish embryo toxicity test (FET) with the zebrafish (Danio rerio) a potential alternative for the fish acute toxicity test? Comp Biochem Physiol C Toxicol Pharmacol 149: 196-209. doi:10.1016/j.cbpc.2008.11.006 PMID: 19095081.
38. Kaur P, Thiruchelvan M, Lee RC, Chen H, Chen KC, Ng ML, et al. (2013) Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrob Agents Chemother 57: 155-167. doi:10.1128/AAC.01467-12 PMID: 23275491.
39. Madsen C, Hooper I, Lundberg L, Shafagati N, Johnson A, Senina S, et al. (2014) Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication. Antiviral Res 112: 26-37. doi:10.1016/j.antiviral.2014.10.002 PMID: 25448087.
40. Chijioke CP, Umeh RE, Mbah AU, Nwonu P, Fleckenstein LL. (1998) Clinical pharmacokinetics of suramin in patients with onchocerciasis. Eur J Clin Pharmacol 54: 249-251. PMID: 9681668.
41. Rashad AA, Keller PA (2013) Structure based design towards the identification of novel binding sites and inhibitors for the chikungunya virus envelope proteins. J Mol Graph Model 44: 241-252. doi:10.1016/j.jmgm.2013.07.001 PMID: 23911992.
42. Rashad AA, Mahalingam S, Keller PA. (2014) Chikungunya virus: emerging targets and new opportunities for medicinal chemistry. J Med Chem 57: 1147-1166. doi:10.1021/jm400460d PMID: 24079775.
43. Gardner CL, Hritz J, Sun C, Vanlandingham DL, Song TY, Ghedin E, et al. (2014) Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: A model for rational arboviral vaccine design. PLoS Negl Trop Dis 8: e2719. doi:10.1371/journal.pntd.0002719 PMID: 24587470.
44. Silva LA, Khomandiak S, Ashbrook AW, Weller R, Heise MT, Morrison TE, et al. (2014) A single-aminoacid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization. J Virol 88: 2385-2397. doi:10.1128/JVI.03116-13 PMID: 24371059.
45. Tan CW, Poh CL, Sam IC, Chan YF. (2013) Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol 87: 611-620. doi:10.1128/JVI.02226-12 PMID: 23097443.
46. Basu A, Beyene A, Meyer K, Ray R. (2004) The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system. J Virol 78: 4478-4486. PMID: 15078928.
47. Sjoberg M, Garoff H (2003) Interactions between the transmembrane segments of the alphavirus E1 and E2 proteins play a role in virus budding and fusion. J Virol 77: 3441-3450. PMID: 12610119.
48. Masrinoul P, Puiprom O, Tanaka A, Kuwahara M, Chaichana P, Ikuta K, et al. (2014) Monoclonal antibody targeting chikungunya virus envelope 1 protein inhibits virus release. Virology 464-465: 111- 117. doi:10.1016/j.virol.2014.05.038 PMID: 25063884.
49. Mastrangelo E, Mazzitelli S, Fabbri J, Rohayem J, Ruokolainen J, Nykänen A, et al. (2014) Delivery of Suramin as an Antiviral Agent through Liposomal Systems. Chem Med Chem 9: 933-939. doi:10.1002/cmdc.201300563 PMID: 24616282.
50. Dingwell KS, Brunetti CR, Hendricks RL, Tang Q, Tang M, Rainbow AJ, et al. (1994) Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J Virol 68: 834-845. PMID: 8289387.
51. Monel B, Beaumont E, Vendrame D, Schwartz O, Brand D, Mammano F. (2012) HIV cell-to-cell transmission requires the production of infectious virus particles and does not proceed through env-mediated fusion pores. J Virol 86: 3924-3933. doi:10.1128/JVI.06478-11 PMID: 22258237.
52. Al Olaby RR, Cocquerel L, Zemla A, Saas L, Dubuisson J, Vielmetter J, et al. (2014) Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein. PLoS One 9: e111333. doi:10.1371/journal.pone.0111333 PMID: 25357246.
53. Brindley MA, Chaudhury S, Plemper RK (2015) Measles Virus Glycoprotein Complexes Preassemble Intracellularly and Relax during Transport to the Cell Surface in Preparation for Fusion. J Virol 89: 1230-1241. doi:10.1128/JVI.02754-14 PMID: 25392208.